Management and Patient-Engagement Strategies for HF Patients with Devices - PARTICIPATE
Project Lead
Professor Aravinda Thiagalingham, University of Sydney
Project Team
Prof Clara Chow, University of Sydney; Dr Brodie Sheahen, University of Sydney; Prof Tim Shaw, University of Sydney; Dr Liliana Laranjo, University of Sydney; Rahul Sathiaraj, University of Sydney; Naveed Khan, BIOTRONIK; Jan Ewert, BIOTRONIK
Industry Partner
BIOTRONIK Australia Pty Ltd
Project Summary
Problem
Patients with Cardiac Implanted Electronic Devices (CIEDs), such as those managing heart failure and atrial fibrillation, face a high disease burden and substantial healthcare costs. Despite the advantages of remote monitoring, there is a significant gap in effective, low-cost digital tools for bi-directional communication between patients and healthcare teams. This gap results in frequent hospital readmissions and suboptimal patient outcomes
Solution
The University of Sydney, in collaboration with Biotronik Australia, aims to enhance patient engagement and outcomes for individuals with CIEDs by leveraging remote monitoring and digital health tools. The project will evaluate an intelligent patient engagement program for patients with BIOTRONIK’s CIED devices. Key activities include assessing clinician and patient perspectives on current CIED remote monitoring, analysing public data on remote monitoring usage, and conducting a clinical trial to pilot an SMS-based patient engagement protocol.
Impact
The integration of patient engagement strategies with remote monitoring data aims to reduce hospital readmissions and improve patient outcomes. By creating cost-effective care models, the project has the potential to save the healthcare system significant costs. The findings will inform future regulatory and commercial strategies for digital health products, enhancing the overall management of CIED patients. Continuous engagement with patients, clinicians, and industry stakeholders will ensure the project's relevance and effectiveness, ultimately leading to better health outcomes and reduced healthcare costs for patients with CIEDs.
